Cochlear Implant Encapsulant Sealing Biofilm Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Cochlear implant systems face biofilm formation and subsequent infections due to openings in the encapsulant, leading to device failure and the need for costly surgeries to replace implanted components.
Innovation Solution
The cochlear implant assembly features a conductive and non-conductive portion encapsulant that completely covers the casing, eliminating voids and reducing biofilm formation, with the conductive portion serving as the ground electrode and the non-conductive portion covering the remaining surface areas, thereby minimizing susceptibility to infections and device failure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If openings are provided in the encapsulant for ground electrode and magnet pocket access, then electrical functionality and magnet placement are enabled, but biofilm formation and infection risk increase
Solution Approach 1:
The patent applies this principle by using a thin film barrier layer that conforms to the encapsulant surface and completely seals openings. This flexible film prevents biofilm formation while maintaining electrical ground functionality and magnet pocket access, resolving the contradiction between device functionality and infection prevention.
Solution Approach 2:
The patent uses composite materials by combining the encapsulant material with a biocompatible conductive coating or barrier layer. This composite structure provides both the electrical conductivity needed for ground electrodes and the biofilm-resistant properties required to prevent infections, addressing both functionality and safety requirements.
2Ease of manufacture
If conventional encapsulant design with openings is used, then manufacturing and assembly are simplified, but device failure and replacement surgery requirements increase
Solution Approach 1:
The patent applies preliminary action by pre-coating the encapsulant with a biocompatible conductive material or barrier layer during the manufacturing process. This preliminary protective action prevents biofilm formation before implantation, extending device longevity without complicating the manufacturing process.
Solution Approach 2:
The patent changes the surface parameters of the encapsulant by modifying its chemical composition or surface properties through coating techniques. This parameter change makes the surface resistant to biofilm formation while maintaining electrical conductivity, thereby extending device life without requiring complex manufacturing changes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This design reduces biofilm formation and infection risks, making the cochlear implant systems more robust and easier to manage, potentially extending their operational life and reducing clinical distress for recipients.
Implementation Method 1
a conductive portion configured to cover at least a substantial portion of the first surface area of the casing and be in conductive contact with the first surface area such that the conductive portion serves as the ground electrode
Data Source
AI summary
An exemplary cochlear implant assembly includes an implantable cochlear stimulator (ICS) configured to apply electrical stimulation to a recipient by way of an electrode array. The ICS is housed in a casing that comprises a first surface area configured to serve as a current path to ground for the electrical stimulation and a second surface area. The cochlear implant assembly further includes an encapsulant that includes a conductive portion configured to cover the first surface area of the casing and be in conductive contact with the first surface area such that the conductive portion serves as the ground electrode and a non-conductive portion configured to cover the second surface area of the casing such that the casing is entirely disposed within the conductive and non-conductive portions of the encapsulant. Corresponding methods for manufacturing cochlear implant assemblies are also described.